Market revenue in 2022 | USD 51.4 million |
Market revenue in 2030 | USD 98.3 million |
Growth rate | 8.4% (CAGR from 2022 to 2030) |
Largest segment | Dermal fillers |
Fastest growing segment | Ophthalmic |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Dermal fillers was the largest segment with a revenue share of 53.89% in 2022. Horizon Databook has segmented the Mexico hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
Mexico is among the top 10 leading countries in terms of the number of hyaluronic acid-based dermal filler procedures. According to ISAPS, the country ranked sixth with 123,707 hyaluronic acid procedures in 2020.
Furthermore, it was the second most commonly performed nonsurgical esthetic procedure in Mexico. Over 10% of international travelers visited Mexico for cosmetic procedures in 2019. Approximately 20 million tourists visit Mexico every year, of which almost 80% are from the U.S. The high demand for cosmetic treatments in Mexico is creating growth opportunities in the market.
According to a study named “Epidemiology of Cataract in the Mexican Population by 2020,” it is estimated that there will be 23 million adults aged 50 and above in Mexico, many of whom will have a visually significant cataract in need of surgery.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico hyaluronic acid market , including forecasts for subscribers. This country databook contains high-level insights into Mexico hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account